Purchases and Sales Made in Q4 2024 in Enanta Pharmaceuticals Inc (ENTA)
This table provides information about the institutional ownership of Enanta Pharmaceuticals Inc (ENTA) during Q4 2024. The information is specifically focused on institutions that hold shares of ENANTA PHARMACEUTICALS INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
BUY
|
- |
49.1K+ 34.11% |
$282K - $637K
|
193K
$985K
|
|
Jan 23, 2025
Q4 2024
|
Cibc World Market Inc.
Toronto, A6 |
BUY
|
- |
18.7KNew |
$108K - $243K
|
18.7K
$95.7K
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
4.49KNew |
$25.8K - $58.4K
|
4.49K
$23K
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
2.3KNew |
$13.2K - $29.9K
|
2.3K
$11.8K
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
926+ 2.56% |
$5.32K - $12K
|
37.1K
$190K
|
|
Jan 27, 2025
Q4 2024
|
Mirae Asset Global Investments Co., Ltd.
|
BUY
|
- |
706New |
$4.06K - $9.17K
|
706
$3.61K
|
|
Jan 27, 2025
Q4 2024
|
Private Wealth Management Group, LLC
Princeton, NJ |
BUY
|
- |
96New |
$552 - $1.25K
|
96
$491
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-2.29K- 81.08% |
$13.2K - $29.8K
|
535
$2.73K
|